Andrew Cannon

2PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 07, 2021
Mucin Expression and Splicing Determine Novel Subtypes and Patient Mortality in Pancreatic Ductal Adenocarcinoma.

Christopher M Thompson, Andrew Cannon, Sean West

|Sep 03, 2020
CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma.

Andrew Cannon, Christopher M Thompson, H Carlo Maurer

Pageof 1